MyAverix Finance
HK · Healthcare
Shanghai Fosun Pharmaceutical Group Co Ltd (2196)
Drug Manufacturers - Specialty & Generic
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $46.68B, P/E ratio is 11.58, net margin is 8.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2196
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) — FAQ
What is Shanghai Fosun Pharmaceutical Group Co Ltd's market cap?
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) has a reported market cap of $46.68B (data as of 2026-05-21).
What is 2196's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Fosun Pharmaceutical Group Co Ltd (2196) is 11.58 (data as of 2026-05-21).
Does Shanghai Fosun Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Fosun Pharmaceutical Group Co Ltd (2196). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Fosun Pharmaceutical Group Co Ltd in?
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2196 listed on?
2196 is listed on HK.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's net margin?
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) reports a net margin of 8.2% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.